Wall Street just revealed a surprising new potential winner and loser of the Ozempic craze

• The rise of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro could have wide-ranging impacts on the economy.
• Now, Wall Street is highlighting stocks that could be potential winners and losers from the rise of the drugs.
• Analysts suggested restaurants will lose and airlines will win if tens of millions of Americans shed billions of pounds. 

The rise of diabetes drugs like Ozempic, Wegovy, and Mounjaro could have far-reaching impacts on a variety of sectors, and investors are scrambling to identify the potential winners and losers.